NASDAQ · Shell Companies · USD

Inflection Point Acquisition Corp. VII (IPXG) Stock Analysis

Inflection Point Acquisition Corp. VII (IPXG) is a Shell Companies stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

IPXG

$10.10

+$0.02 (+0.15%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare IPXG with… →

IPXG Key Statistics

As of Oct 21, 2026

Trading

Open: $10.09
Previous Close: $10.08
Day's Range: 10.09–10.10
52-Week Range: 9.76–10.22
Volume: 672.00

Valuation

Market Cap: $316.29M

Financials (FY)

Shares Outstanding: 23.67M

Dividend and dates

Avg Volume: 99.93K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

Inflection Point Acquisition Corp. VII (IPXG) has a market capitalization of $316.29M.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Inflection Point Acquisition Corp. VII (IPXG) at $316.29M. It is classified in the Shell Companies industry, within the Financial Services sector.

The 52-week range on file runs from $9.76 to $10.22. The most recent close on file for IPXG is $10.10, dated October 21, 2026. That is +$0.02 (+0.15%) against the previous close. The latest close sits 3.43% above that 52-week low.

Valuation Assessment

The stored price history starts on February 27, 2026, and the total return since then is +2.91%.

Growth & Income

The record shows no dividend for IPXG.

So far in 2026 the total return is +2.91%.

Peer Comparison

Inflection Point Acquisition Corp. VII (IPXG) operates in the Shell Companies industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Inflection Point Acquisition Corp. VII	IPXG	$316.29M	—
Vylor Inc.	VYLR	$49.89B	106.8
Drugs Made In America Acquisition II Corp.	DMII	$649.10M	34.0
Churchill Capital Corp XI	CCXI	$621.61M	—

The Shell Companies industry average P/E ratio is 49.2x. Inflection Point Acquisition Corp. VII has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Shell Companies Stocks

VYLR

Vylor Inc.

$49.89B

DMII

Drugs Made In America Acquisition II Corp.

$649.10M

CCXI

Churchill Capital Corp XI

$621.61M

EVAC

EQV Ventures Acquisition Corp. II

$603.77M

BCSS

Bain Capital GSS Investment Corp.

$596.26M

CEPF

Cantor Equity Partners IV, Inc.

$587.79M

View all Shell Companies stocks →

Popular Financial Services Stocks

BRK-B

Berkshire Hathaway Inc.

$1.11T

JPM

JPMorgan Chase & Co.

$890.13B

Visa Inc.

$765.68B

Mastercard Incorporated

$545.42B

BAC

Bank of America Corporation

$358.24B

View all Financial Services stocks →

About Inflection Point Acquisition Corp. VII

Inflection Point Acquisition Corp. VII does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as Columbus Circle Capital Corp II and changed its name to Inflection Point Acquisition Corp. VII in August 2026. The company was incorporated in 2025 and is based in New York, New York.